Article Details

PhaseBio Pharmaceuticals (PHAS) Given a $27.00 Price Target at Citigroup

Retrieved on: 2019-05-27 11:45:00

Tags for this article:

Click the tags to see associated articles and topics

PhaseBio Pharmaceuticals (PHAS) Given a $27.00 Price Target at Citigroup. View article details on hiswai:

Excerpt

<div>Finally, <b>Schonfeld Strategic Advisors</b> LLC bought a new position in PhaseBio Pharmaceuticals during the 1st quarter worth approximately $600,000.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up